img

Global Acamprosate Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acamprosate Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Campral is a brand name of Acamprosate, and Acamprosate is sold under the brand name Campral, Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analogue of the amino acid neurotransmitter γ-aminobutyric acid and the amino acid neuromodulator taurine. Its chemical name is calcium acetylaminopropane sulfonate. Each Campral® tablet contains acamprosate calcium 333 mg, equivalent to 300 mg of acamprosate. Inactive ingredients in Campral tablets includecrospovidone, microcrystalline cellulose, magnesium silicate, sodium starch glycolate, colloidal anhydrous silica, magnesium stearate, talc, propylene glycol and Eudragit L 30 D or equivalent. Sulfites were used in the synthesis of the drug substance and traces of residual sulfites may be present in the drug product.
The global Acamprosate market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Acamprosate is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Acamprosate is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Acamprosate is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Acamprosate include Merck Group, Zydus Pharmaceuticals, Mylan, Teva and Glenmark Pharmaceuticals, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Acamprosate, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Acamprosate by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Acamprosate market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Acamprosate market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Merck Group
Zydus Pharmaceuticals
Mylan
Teva
Glenmark Pharmaceuticals
By Type
333 mg Delayed Release Tablet
Others
By Application
Hospital
Clinic
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Acamprosate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Acamprosate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acamprosate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Acamprosate Definition
1.2 Market by Type
1.2.1 Global Acamprosate Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 333 mg Delayed Release Tablet
1.2.3 Others
1.3 Market Segment by Application
1.3.1 Global Acamprosate Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Acamprosate Sales
2.1 Global Acamprosate Revenue Estimates and Forecasts 2018-2034
2.2 Global Acamprosate Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Acamprosate Revenue by Region
2.3.1 Global Acamprosate Revenue by Region (2018-2024)
2.3.2 Global Acamprosate Revenue by Region (2024-2034)
2.4 Global Acamprosate Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Acamprosate Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Acamprosate Sales Quantity by Region
2.6.1 Global Acamprosate Sales Quantity by Region (2018-2024)
2.6.2 Global Acamprosate Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Acamprosate Sales Quantity by Manufacturers
3.1.1 Global Acamprosate Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Acamprosate Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Acamprosate Sales in 2022
3.2 Global Acamprosate Revenue by Manufacturers
3.2.1 Global Acamprosate Revenue by Manufacturers (2018-2024)
3.2.2 Global Acamprosate Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Acamprosate Revenue in 2022
3.3 Global Acamprosate Sales Price by Manufacturers
3.4 Global Key Players of Acamprosate, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Acamprosate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Acamprosate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Acamprosate, Product Offered and Application
3.8 Global Key Manufacturers of Acamprosate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Acamprosate Sales Quantity by Type
4.1.1 Global Acamprosate Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Acamprosate Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Acamprosate Sales Quantity Market Share by Type (2018-2034)
4.2 Global Acamprosate Revenue by Type
4.2.1 Global Acamprosate Historical Revenue by Type (2018-2024)
4.2.2 Global Acamprosate Forecasted Revenue by Type (2024-2034)
4.2.3 Global Acamprosate Revenue Market Share by Type (2018-2034)
4.3 Global Acamprosate Price by Type
4.3.1 Global Acamprosate Price by Type (2018-2024)
4.3.2 Global Acamprosate Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Acamprosate Sales Quantity by Application
5.1.1 Global Acamprosate Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Acamprosate Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Acamprosate Sales Quantity Market Share by Application (2018-2034)
5.2 Global Acamprosate Revenue by Application
5.2.1 Global Acamprosate Historical Revenue by Application (2018-2024)
5.2.2 Global Acamprosate Forecasted Revenue by Application (2024-2034)
5.2.3 Global Acamprosate Revenue Market Share by Application (2018-2034)
5.3 Global Acamprosate Price by Application
5.3.1 Global Acamprosate Price by Application (2018-2024)
5.3.2 Global Acamprosate Price Forecast by Application (2024-2034)
6 North America
6.1 North America Acamprosate Sales by Company
6.1.1 North America Acamprosate Revenue by Company (2018-2024)
6.1.2 North America Acamprosate Sales Quantity by Company (2018-2024)
6.2 North America Acamprosate Market Size by Type
6.2.1 North America Acamprosate Sales Quantity by Type (2018-2034)
6.2.2 North America Acamprosate Revenue by Type (2018-2034)
6.3 North America Acamprosate Market Size by Application
6.3.1 North America Acamprosate Sales Quantity by Application (2018-2034)
6.3.2 North America Acamprosate Revenue by Application (2018-2034)
6.4 North America Acamprosate Market Size by Country
6.4.1 North America Acamprosate Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Acamprosate Revenue by Country (2018-2034)
6.4.3 North America Acamprosate Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Acamprosate Sales by Company
7.1.1 Europe Acamprosate Sales Quantity by Company (2018-2024)
7.1.2 Europe Acamprosate Revenue by Company (2018-2024)
7.2 Europe Acamprosate Market Size by Type
7.2.1 Europe Acamprosate Sales Quantity by Type (2018-2034)
7.2.2 Europe Acamprosate Revenue by Type (2018-2034)
7.3 Europe Acamprosate Market Size by Application
7.3.1 Europe Acamprosate Sales Quantity by Application (2018-2034)
7.3.2 Europe Acamprosate Revenue by Application (2018-2034)
7.4 Europe Acamprosate Market Size by Country
7.4.1 Europe Acamprosate Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Acamprosate Revenue by Country (2018-2034)
7.4.3 Europe Acamprosate Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Acamprosate Sales by Company
8.1.1 China Acamprosate Sales Quantity by Company (2018-2024)
8.1.2 China Acamprosate Revenue by Company (2018-2024)
8.2 China Acamprosate Market Size by Type
8.2.1 China Acamprosate Sales Quantity by Type (2018-2034)
8.2.2 China Acamprosate Revenue by Type (2018-2034)
8.3 China Acamprosate Market Size by Application
8.3.1 China Acamprosate Sales Quantity by Application (2018-2034)
8.3.2 China Acamprosate Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Acamprosate Sales by Company
9.1.1 APAC Acamprosate Sales Quantity by Company (2018-2024)
9.1.2 APAC Acamprosate Revenue by Company (2018-2024)
9.2 APAC Acamprosate Market Size by Type
9.2.1 APAC Acamprosate Sales Quantity by Type (2018-2034)
9.2.2 APAC Acamprosate Revenue by Type (2018-2034)
9.3 APAC Acamprosate Market Size by Application
9.3.1 APAC Acamprosate Sales Quantity by Application (2018-2034)
9.3.2 APAC Acamprosate Revenue by Application (2018-2034)
9.4 APAC Acamprosate Market Size by Region
9.4.1 APAC Acamprosate Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Acamprosate Revenue by Region (2018-2034)
9.4.3 APAC Acamprosate Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Acamprosate Sales by Company
10.1.1 Middle East, Africa and Latin America Acamprosate Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Acamprosate Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Acamprosate Market Size by Type
10.2.1 Middle East, Africa and Latin America Acamprosate Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Acamprosate Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Acamprosate Market Size by Application
10.3.1 Middle East, Africa and Latin America Acamprosate Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Acamprosate Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Acamprosate Market Size by Country
10.4.1 Middle East, Africa and Latin America Acamprosate Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Acamprosate Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Acamprosate Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck Group
11.1.1 Merck Group Company Information
11.1.2 Merck Group Overview
11.1.3 Merck Group Acamprosate Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Group Acamprosate Products and Services
11.1.5 Merck Group Acamprosate SWOT Analysis
11.1.6 Merck Group Recent Developments
11.2 Zydus Pharmaceuticals
11.2.1 Zydus Pharmaceuticals Company Information
11.2.2 Zydus Pharmaceuticals Overview
11.2.3 Zydus Pharmaceuticals Acamprosate Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Zydus Pharmaceuticals Acamprosate Products and Services
11.2.5 Zydus Pharmaceuticals Acamprosate SWOT Analysis
11.2.6 Zydus Pharmaceuticals Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Acamprosate Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Mylan Acamprosate Products and Services
11.3.5 Mylan Acamprosate SWOT Analysis
11.3.6 Mylan Recent Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Overview
11.4.3 Teva Acamprosate Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Teva Acamprosate Products and Services
11.4.5 Teva Acamprosate SWOT Analysis
11.4.6 Teva Recent Developments
11.5 Glenmark Pharmaceuticals
11.5.1 Glenmark Pharmaceuticals Company Information
11.5.2 Glenmark Pharmaceuticals Overview
11.5.3 Glenmark Pharmaceuticals Acamprosate Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Glenmark Pharmaceuticals Acamprosate Products and Services
11.5.5 Glenmark Pharmaceuticals Acamprosate SWOT Analysis
11.5.6 Glenmark Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Acamprosate Value Chain Analysis
12.2 Acamprosate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Acamprosate Production Mode & Process
12.4 Acamprosate Sales and Marketing
12.4.1 Acamprosate Sales Channels
12.4.2 Acamprosate Distributors
12.5 Acamprosate Customers
13 Market Dynamics
13.1 Acamprosate Industry Trends
13.2 Acamprosate Market Drivers
13.3 Acamprosate Market Challenges
13.4 Acamprosate Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Acamprosate Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 333 mg Delayed Release Tablet
Table 3. Major Manufacturers of Others
Table 4. Global Acamprosate Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Acamprosate Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Acamprosate Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Acamprosate Revenue Market Share by Region (2018-2024)
Table 8. Global Acamprosate Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Acamprosate Revenue Market Share by Region (2024-2034)
Table 10. Global Acamprosate Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Acamprosate Sales by Region (2018-2024) & (K Units)
Table 12. Global Acamprosate Sales Market Share by Region (2018-2024)
Table 13. Global Acamprosate Sales by Region (2024-2034) & (K Units)
Table 14. Global Acamprosate Sales Market Share by Region (2024-2034)
Table 15. Global Acamprosate Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Acamprosate Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Acamprosate Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Acamprosate Revenue Share by Manufacturers (2018-2024)
Table 19. Global Acamprosate Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Acamprosate, Industry Ranking, 2021 VS 2022
Table 21. Global Acamprosate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Acamprosate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acamprosate as of 2022)
Table 23. Global Key Manufacturers of Acamprosate, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Acamprosate, Product Offered and Application
Table 25. Global Key Manufacturers of Acamprosate, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Acamprosate Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Acamprosate Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Acamprosate Sales Quantity Share by Type (2018-2024)
Table 30. Global Acamprosate Sales Quantity Share by Type (2024-2034)
Table 31. Global Acamprosate Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Acamprosate Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Acamprosate Revenue Share by Type (2018-2024)
Table 34. Global Acamprosate Revenue Share by Type (2024-2034)
Table 35. Acamprosate Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Acamprosate Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Acamprosate Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Acamprosate Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Acamprosate Sales Quantity Share by Application (2018-2024)
Table 40. Global Acamprosate Sales Quantity Share by Application (2024-2034)
Table 41. Global Acamprosate Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Acamprosate Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Acamprosate Revenue Share by Application (2018-2024)
Table 44. Global Acamprosate Revenue Share by Application (2024-2034)
Table 45. Acamprosate Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Acamprosate Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Acamprosate Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Acamprosate Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Acamprosate Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Acamprosate Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Acamprosate Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Acamprosate Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Acamprosate Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Acamprosate Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Acamprosate Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Acamprosate Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Acamprosate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Acamprosate Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Acamprosate Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Acamprosate Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Acamprosate Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Acamprosate Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Acamprosate Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Acamprosate Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Acamprosate Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Acamprosate Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Acamprosate Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Acamprosate Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Acamprosate Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Acamprosate Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Acamprosate Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Acamprosate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Acamprosate Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Acamprosate Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Acamprosate Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Acamprosate Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Acamprosate Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Acamprosate Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Acamprosate Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Acamprosate Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Acamprosate Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Acamprosate Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Acamprosate Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Acamprosate Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Acamprosate Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Acamprosate Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Acamprosate Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Acamprosate Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Acamprosate Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Acamprosate Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Acamprosate Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Acamprosate Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Acamprosate Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Acamprosate Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Acamprosate Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Acamprosate Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Acamprosate Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Acamprosate Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Acamprosate Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Acamprosate Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Acamprosate Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Acamprosate Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Acamprosate Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Acamprosate Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Acamprosate Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Acamprosate Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Acamprosate Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Acamprosate Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Acamprosate Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Acamprosate Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Acamprosate Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Acamprosate Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Acamprosate Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Acamprosate Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Acamprosate Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Acamprosate Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Merck Group Company Information
Table 118. Merck Group Description and Overview
Table 119. Merck Group Acamprosate Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Merck Group Acamprosate Product and Services
Table 121. Merck Group Acamprosate SWOT Analysis
Table 122. Merck Group Recent Developments
Table 123. Zydus Pharmaceuticals Company Information
Table 124. Zydus Pharmaceuticals Description and Overview
Table 125. Zydus Pharmaceuticals Acamprosate Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Zydus Pharmaceuticals Acamprosate Product and Services
Table 127. Zydus Pharmaceuticals Acamprosate SWOT Analysis
Table 128. Zydus Pharmaceuticals Recent Developments
Table 129. Mylan Company Information
Table 130. Mylan Description and Overview
Table 131. Mylan Acamprosate Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Mylan Acamprosate Product and Services
Table 133. Mylan Acamprosate SWOT Analysis
Table 134. Mylan Recent Developments
Table 135. Teva Company Information
Table 136. Teva Description and Overview
Table 137. Teva Acamprosate Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Teva Acamprosate Product and Services
Table 139. Teva Acamprosate SWOT Analysis
Table 140. Teva Recent Developments
Table 141. Glenmark Pharmaceuticals Company Information
Table 142. Glenmark Pharmaceuticals Description and Overview
Table 143. Glenmark Pharmaceuticals Acamprosate Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Glenmark Pharmaceuticals Acamprosate Product and Services
Table 145. Glenmark Pharmaceuticals Acamprosate SWOT Analysis
Table 146. Glenmark Pharmaceuticals Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Acamprosate Distributors List
Table 150. Acamprosate Customers List
Table 151. Acamprosate Market Trends
Table 152. Acamprosate Market Drivers
Table 153. Acamprosate Market Challenges
Table 154. Acamprosate Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Acamprosate Product Picture
Figure 2. Global Acamprosate Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Acamprosate Market Share by Type in 2022 & 2034
Figure 4. 333 mg Delayed Release Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Acamprosate Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Acamprosate Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Acamprosate Report Years Considered
Figure 12. Global Acamprosate Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Acamprosate Revenue 2018-2034 (US$ Million)
Figure 14. Global Acamprosate Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Acamprosate Sales Quantity 2018-2034 (K Units)
Figure 16. Global Acamprosate Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Acamprosate Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Acamprosate Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Acamprosate Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Acamprosate Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Acamprosate Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Acamprosate Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Acamprosate Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Acamprosate Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Acamprosate Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Acamprosate Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Acamprosate Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Acamprosate Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Acamprosate Revenue in 2022
Figure 30. Acamprosate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Acamprosate Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Acamprosate Revenue Market Share by Type (2018-2034)
Figure 33. Global Acamprosate Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Acamprosate Revenue Market Share by Application (2018-2034)
Figure 35. North America Acamprosate Revenue Market Share by Company in 2022
Figure 36. North America Acamprosate Sales Quantity Market Share by Company in 2022
Figure 37. North America Acamprosate Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Acamprosate Revenue Market Share by Type (2018-2034)
Figure 39. North America Acamprosate Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Acamprosate Revenue Market Share by Application (2018-2034)
Figure 41. North America Acamprosate Revenue Share by Country (2018-2034)
Figure 42. North America Acamprosate Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Acamprosate Sales Quantity Market Share by Company in 2022
Figure 46. Europe Acamprosate Revenue Market Share by Company in 2022
Figure 47. Europe Acamprosate Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Acamprosate Revenue Market Share by Type (2018-2034)
Figure 49. Europe Acamprosate Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Acamprosate Revenue Market Share by Application (2018-2034)
Figure 51. Europe Acamprosate Revenue Share by Country (2018-2034)
Figure 52. Europe Acamprosate Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 54. France Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 58. China Acamprosate Sales Quantity Market Share by Company in 2022
Figure 59. China Acamprosate Revenue Market Share by Company in 2022
Figure 60. China Acamprosate Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Acamprosate Revenue Market Share by Type (2018-2034)
Figure 62. China Acamprosate Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Acamprosate Revenue Market Share by Application (2018-2034)
Figure 64. APAC Acamprosate Sales Quantity Market Share by Company in 2022
Figure 65. APAC Acamprosate Revenue Market Share by Company in 2022
Figure 66. APAC Acamprosate Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Acamprosate Revenue Market Share by Type (2018-2034)
Figure 68. APAC Acamprosate Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Acamprosate Revenue Market Share by Application (2018-2034)
Figure 70. APAC Acamprosate Revenue Share by Region (2018-2034)
Figure 71. APAC Acamprosate Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 76. India Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Acamprosate Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Acamprosate Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Acamprosate Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Acamprosate Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Acamprosate Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Acamprosate Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Acamprosate Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Acamprosate Revenue Share by Country (2018-2034)
Figure 85. Brazil Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Acamprosate Revenue (2018-2034) & (US$ Million)
Figure 90. Acamprosate Value Chain
Figure 91. Acamprosate Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed